32.63
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RARE Giù?
Forum
Previsione
Frazionamento azionario
Ultragenyx Pharmaceutical Inc Borsa (RARE) Ultime notizie
Chart based analysis of Ultragenyx Pharmaceutical Inc. trendsJuly 2025 Patterns & Expert Curated Trade Setups - newser.com
Will Ultragenyx Pharmaceutical Inc. see short term momentumTrade Volume Report & Low Risk High Reward Ideas - newser.com
Does Ultragenyx Pharmaceutical Inc. fit your quant trading model2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Understanding Ultragenyx Pharmaceutical Inc.’s price movementMarket Trend Review & Smart Investment Allocation Insights - newser.com
Why Ultragenyx Pharmaceutical Inc. stock appeals to dividend seekersQuarterly Trade Report & Fast Moving Stock Watchlists - newser.com
What moving averages say about Ultragenyx Pharmaceutical Inc.July 2025 Gainers & Verified Technical Signals - newser.com
Ultragenyx: Rough Road Ahead Despite Growing Revenues And Catalysts - Seeking Alpha
Earnings visualization tools for Ultragenyx Pharmaceutical Inc.Trade Ideas & Long Hold Capital Preservation Tips - newser.com
Will Ultragenyx Pharmaceutical Inc. stock benefit from upcoming earnings reportsWeekly Risk Report & Free Verified High Yield Trade Plans - newser.com
Ultragenyx CFO Horn sells $250k in shares By Investing.com - Investing.com South Africa
Ultragenyx CFO Horn sells $250k in shares - Investing.com
Wedbush Lifts Price Target on Ultragenyx Pharmaceutical to $35 From $34, Keeps Neutral Rating - MarketScreener
What sentiment indicators say about Ultragenyx Pharmaceutical Inc. stock2025 Bull vs Bear & Stock Portfolio Risk Control - newser.com
Is Ultragenyx Pharmaceutical Inc. stock attractive after correctionPortfolio Update Summary & AI Enhanced Trading Signals - newser.com
Sentiment analysis tools applied to Ultragenyx Pharmaceutical Inc.Market Sentiment Review & Safe Capital Growth Stock Tips - newser.com
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Can Ultragenyx Pharmaceutical Inc. (UP0) stock hold up in economic slowdownJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
Ultragenyx Pharmaceutical Inc. stock prediction for this weekWeekly Trade Review & Reliable Trade Execution Plans - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Ultragenyx Pharmaceutical (NASDAQ:RARE) - MarketBeat
Does Ultragenyx Pharmaceutical Inc. show high probability of reboundWeekly Risk Report & Advanced Swing Trade Entry Plans - newser.com
Predicting Ultragenyx Pharmaceutical Inc. trend using moving averagesJuly 2025 Chart Watch & Safe Entry Point Identification - newser.com
What drives Ultragenyx Pharmaceutical Inc stock priceTechnical Analysis Insights & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Wealth Enhancement Advisory Services LLC Takes $353,000 Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Bank of America Securities Remains Bullish on Ultragenyx Pharmaceutical (RARE) - Yahoo Finance
14 Biotech Stocks with High Potential - Insider Monkey
Ultragenyx Pharmaceutical Inc. (RARE) Investor Outlook: Unpacking the 187.83% Upside Potential - DirectorsTalk Interviews
Pattern recognition hints at Ultragenyx Pharmaceutical Inc. upsideWeekly Volume Report & High Conviction Buy Zone Picks - newser.com
Why Ultragenyx Pharmaceutical Inc. (UP0) stock signals breakout potentialJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - newser.com
How to read the order book for Ultragenyx Pharmaceutical Inc.Share Buyback & Free Daily Entry Point Trade Alerts - newser.com
Ultragenyx Pharmaceutical Inc. stock trend outlook and recovery path2025 Key Lessons & Weekly High Potential Stock Alerts - newser.com
Will Ultragenyx Pharmaceutical Inc. (UP0) stock outperform energy sector in 2025Watch List & High Accuracy Swing Entry Alerts - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):